Breaking
Translucent raises $27M Series A led by GV $34M total raised in under a year Early customers automate 97% of routine financial analysis 56% more finance-team capacity, zero new headcount Northwestern Medicine, Duly Health & Springfield Clinic on board Nearly 40% of US hospitals run negative margins "Like ChatGPT for provider finances" Translucent raises $27M Series A led by GV $34M total raised in under a year Early customers automate 97% of routine financial analysis 56% more finance-team capacity, zero new headcount Northwestern Medicine, Duly Health & Springfield Clinic on board Nearly 40% of US hospitals run negative margins "Like ChatGPT for provider finances"
Company Dossier · Healthcare · AI

Translucent AI

Healthcare's financial operating system - a 24/7 AI analyst for the people who keep hospitals solvent.

Founded2024
HQNew York, NY
StageSeries A
Raised$34M
Translucent AI - Healthcare's Financial Operating System
THE WORDMARK. Translucent's own share image. The name is the promise: make the money you can't see - $2.5 trillion of provider finance - finally legible.
Share this dossier LinkedIn Twitter / X Facebook Instagram
The Scene

A CFO stares at a spreadsheet that already lied to her.

Somewhere tonight, a hospital finance team is reconciling last month while this month bleeds.

It is 9 p.m. in a health-system finance office. Orthopedics is down and nobody can say why - not without three days, four disconnected systems, and a consultant's benchmark report that was already stale the week it arrived. This is the ordinary crisis Translucent AI was built to interrupt. Type the question - "What are the largest drivers of expenses for orthopedics this month?" - and the answer comes back in plain language, sourced from the general ledger, the revenue cycle, the EHR, and the payer contracts at once. No pivot table. No super-user. No waiting for Q3 to understand Q1.

Translucent calls itself healthcare's financial operating system. In practice it is closer to what founder Jack O'Hara pitches out loud: a dedicated 24/7 financial analyst that already understands your organization's peculiar structure, its service lines, its acronyms, and the questions you keep meaning to ask but never have the bandwidth to. Providers in the US move roughly $2.5 trillion a year. Startlingly little of it is legible in real time. That gap - between the money moving and the money understood - is the whole business.

$34M
Total raised · Seed + Series A
97%
Routine analysis automated*
56%
More capacity, no new hires*
6
Financial domains covered
Origin

Built by the CIO who watched insight arrive too late.

Before Translucent, Jack O'Hara ran technology inside the machine he now sells to. He was CIO and CPTO at ChenMed, CIO at Springfield Clinic, and a regional technology leader at Mount Sinai - two multi-billion-dollar medical groups and teams of hundreds across product, engineering, and AI. He knows precisely where the data hides because he spent a career being the person asked to find it.

The founding scene is a hard one: a rural clinic that closed, O'Hara says, because the financial insight that might have saved it came too late to act on. The lesson wasn't "hospitals need better dashboards." It was that hospitals and clinics keep being forced to choose between financial health and patient health - and that the choice is usually made in the dark. Translucent is his argument that it doesn't have to be.

Claims
Labor
Clinical output
P&L
Budgets & forecasts
Contract economics

The Founder File

  • Jack O'Hara - Founder & CEO
  • Former CIO / CPTO, ChenMed
  • Former CIO, Springfield Clinic - now a Translucent customer
  • Former regional tech leader, Mount Sinai
  • Led teams of ~300 across product, engineering & AI
  • Company founded 2024 · New York, NY · ~29 people
"Our AI doesn't just surface data - it brings clarity to decisions that were once hidden behind spreadsheets, dashboards, and disconnected systems." - Jack O'Hara, Founder & CEO
The Product

Ask in English. Answer in real time.

Not another dashboard - a translator that answers back.

Translucent is AI-native, healthcare-specific, and - the line O'Hara repeats - built for the non-super-user. The platform translates a plain-language question into queries across every system that touches the money, then learns your terms and your past conversations so the next question lands faster. The point is not prettier charts. The point is the "why" behind the margin.

01

Unify

Pull clinical, operational, and financial data - GLs, revenue cycle, EHRs, payer contracts - into one layer.

02

Ask

Type a question in plain language. "How does our payer mix impact margins by service line?"

03

Act

Agents surface root causes and alert on staffing, clinical ops, and vendor contracts - continuously.

The Agent Hub

Five agents that never clock out.

Always on

P&L & Service Lines

Continuously monitors profitability, drilling from summary financials to general-ledger detail on demand.

Always on

Labor & Productivity

Watches staffing and output, flagging where cost and clinical activity drift apart.

Always on

Revenue Cycle

Tracks claims and the money in motion, surfacing leaks before they compound.

Always on

Managed Care & Contracts

Reads payer contract economics against reality, so terms don't quietly erode margin.

"Understanding the nuances of real-time financials has always been incredibly difficult, manual, and frustrating. Translucent AI changed that almost overnight." - Jen Boyer, CEO, Springfield Clinic
The Money

$34M in under a year - and GV in the lead.

Translucent raised twice before most startups raise once: a $7M oversubscribed seed in August 2025, then a $27M Series A in March 2026 led by GV (Google Ventures). Investors describe the sales cycle as roughly half the length typical of healthcare software - a proxy for how badly the market wants this.

$7M
Seed · Aug 2025
NEA · Virtue · FPV · Redesign Health
$27M
Series A · Mar 2026
GV (lead) · NEA · FPV · Virtue
Timeline

The short, fast history.

2024

Founded in New York by Jack O'Hara. Early customers begin running the platform.

AUGUST 2025

Emerges with a $7M oversubscribed seed round; launches its AI financial analyst for healthcare operators.

MARCH 2026

Announces a $27M Series A led by GV to scale healthcare's financial operating system.

Amuse-Bouche

  • Reporters call it "ChatGPT for provider finances."
  • Springfield Clinic went from O'Hara's employer to O'Hara's customer.
  • Nearly 40% of US hospitals operate at negative margins.
  • Providers process ~$2.5T a year - the market Translucent wants to make legible.
  • The whole thesis, in one line: AI-native, built for healthcare, built for the non-super-user.
The Scene, Revisited

Same 9 p.m. office. Different ending.

Return to the CFO and the spreadsheet that lied. In the version Translucent is selling, she never opens it. She asks a question in plain English and gets the reason orthopedics slipped - this month, not last quarter - with the payer mix and the labor drift already named. The consultant's stale benchmark stays in the drawer. The rural clinic that closed because insight came late is the counterfactual the company keeps in view: not every finance question is life-or-death, but enough of them touch whether a clinic keeps its doors open that the delay itself is the risk.

Whether agentic AI can actually move a hospital's margin - or merely report on it faster and more kindly - is the open question, and a fair one. What Translucent has done is narrow the distance between the money moving and the money understood, from days to a sentence. For a sector where nearly four in ten hospitals run in the red, closing that gap is not a productivity feature. It is, quietly, the point.